Low Globulin Levels: Causes and Diagnostic Considerations

Introduction to Low Globulin Levels

• Low globulin levels result from either decreased immunoglobulin production or increased protein loss through the kidneys, gastrointestinal tract, or lymphatic system, according to the American College of Physicians 1

Primary Causes of Low Globulin Levels

• Agammaglobulinemia is characterized by very low or undetectable immunoglobulins with absent or severely reduced B cells, typically presenting in the first 2 years of life with recurrent bacterial respiratory infections, as stated by the American Academy of Allergy, Asthma, and Immunology 2, 3
• Common Variable Immunodeficiency (CVID) is marked by a variable reduction in ≥2 immunoglobulin classes, with normal or moderately reduced B-cell numbers, often diagnosed after age 4 years, according to the American College of Medical Genetics and Genomics 1, 4
• Selective IgA Deficiency (SIGAD) is defined by IgA <7 mg/dL with normal IgG and IgM levels in patients older than 4 years, affecting approximately 1 in 300-700 white individuals, as reported by the European Academy of Allergy and Clinical Immunology 3
• Dyskeratosis Congenita is a telomere biology disorder presenting with hypogammaglobulinemia, lymphopenia, and impaired antibody responses alongside characteristic skin findings, according to the National Institute of Allergy and Infectious Diseases 2
• Immunodeficiency with Multiple Intestinal Atresia is a SCID-like phenotype with variable immune defects including hypogammaglobulinemia and markedly decreased B- and T-cell counts, as stated by the Society for Immunotherapy of Cancer 2

Secondary Causes of Low Globulin Levels

• Rituximab and anti-CD20 therapies can cause prolonged hypogammaglobulinemia, with 21% of patients on long-term rituximab developing IgG <5 g/L, according to the American Society of Clinical Oncology 5
• Antiepileptic drugs such as phenytoin, carbamazepine, valproic acid, and zonisamide can cause reversible SIGAD and hypogammaglobulinemia, as reported by the American Epilepsy Society 3
• Nephrotic syndrome is a cause of hypogammaglobulinemia due to urinary protein loss, diagnosed by 24-hour urine protein, urine protein/creatinine ratio, and urinalysis, according to the National Kidney Foundation 1
• Protein-losing enteropathy is a gastrointestinal protein loss with chronic diarrhea, assessed by stool alpha-1 antitrypsin clearance and intestinal imaging, as stated by the American Gastroenterological Association 1
• Lymphatic disorders can cause disrupted lymphatic drainage leading to protein loss, according to the American Heart Association 1
• Good syndrome is a thymoma-associated immunodeficiency with late-onset combined immunodeficiency phenotype, similar to CVID but with thymoma present, as reported by the European Society of Medical Oncology 3

Diagnostic Considerations

• A critical pitfall is failing to check albumin and total protein levels, as this simple step distinguishes protein loss syndromes from true immunodeficiency, according to the American College of Physicians 1
• Medication history is essential and often overlooked, as drug-induced hypogammaglobulinemia is frequently reversible with cessation of the offending agent, as stated by the American Academy of Allergy, Asthma, and Immunology 3

Low Globulin Levels: Clinical Ramifications and Causes

Infection Risk and Mortality Impact

• Patients with IgG <400 mg/dL face severe risk of life-threatening bacterial infections, particularly from encapsulated organisms like Streptococcus pneumoniae and Haemophilus influenzae, according to the American Academy of Allergy, Asthma, and Immunology 6
• Recurrent respiratory tract infections are the hallmark presentation of low globulin levels, as stated by the American College of Allergy, Asthma, and Immunology 7
• Hypogammaglobulinemia is associated with decreased overall survival in multiple myeloma patients, as reported by the International Myeloma Society 6

Diagnostic Criteria and Testing

• The diagnostic criteria for Common Variable Immunodeficiency (CVID) include IgG <450-500 mg/dL plus IgA or IgM below 5th percentile, with impaired specific antibody production, as defined by the European Society for Immunodeficiencies 7
• IgG subclass deficiency is diagnosed by measuring all 4 subclasses simultaneously, and confirming abnormal results with repeat measurement ≥1 month apart, as recommended by the American Academy of Allergy, Asthma, and Immunology 7

Treatment and Management

• IVIG replacement therapy is indicated for patients with ≥2 severe recurrent infections by encapsulated bacteria, regardless of exact IgG level, as stated by the International Immunoglobulin Society 6
• Monthly IVIG treatment is recommended for duration of immunoparesis until Ig levels ≥400 mg/dL, as suggested by the European Society for Immunodeficiencies 6
• Serum levels alone are inadequate for monitoring treatment efficacy, and frequency of infections should be monitored as a more important indicator, as reported by the American College of Allergy, Asthma, and Immunology 6

Evidence‑Based Diagnostic and Laboratory Evaluation of Isolated Low Globulin

Differential Diagnosis

• Lymphoproliferative disorders (e.g., multiple myeloma) can cause isolated low globulin despite the presence of a monoclonal protein, reflecting immune paresis. [8][9]

• Lymphadenopathy or hepatosplenomegaly may be a clinical clue pointing toward an underlying lymphoproliferative disorder. 8

First‑Tier Laboratory Testing

• Serum protein electrophoresis with immunofixation should be performed to characterize protein fractions, detect monoclonal proteins, and identify immune paresis. 8

• Quantitative measurement of serum immunoglobulin classes (IgG, IgA, IgM) is essential to determine which immunoglobulin subclasses are reduced. 10

Second‑Tier Functional and Cellular Testing

• Vaccine response testing (protein antigens such as tetanus/diphtheria and polysaccharide antigens such as pneumococcal) evaluates functional antibody production and helps confirm antibody deficiency. 10

• Flow cytometry for B‑cell enumeration assists in distinguishing among primary immunodeficiencies (e.g., CVID vs. selective IgA deficiency). 10

Associated Clinical Features

• Autoimmune manifestations—including arthritis, cytopenias, and granulomatous disease—are frequently observed in patients with common variable immunodeficiency (CVID). 10

Evidence‑Based Guidance for Interpreting a Low‑Normal Gamma Globulin Level

Immunodeficiency Diagnostic Criteria

• Agammaglobulinemia is defined by IgG < 100 mg/dL, IgM < 20 mg/dL, IgA < 10 mg/dL, and CD19⁺ B‑cell frequency < 2 %; a patient with a gamma globulin of 0.7 g/dL does not meet these thresholds. 11, 12, 13

Clinical Assessment of Infection History

• When evaluating possible immunodeficiency, clinicians should document any history of recurrent bacterial respiratory infections (e.g., otitis media, sinusitis, pneumonia) caused by encapsulated organisms such as Streptococcus pneumoniae or Haemophilus influenzae; the presence of such infections supports a clinically significant immunodeficiency, whereas their absence argues against it. 11, 12

Iron‑Deficiency and Immune Function

• Iron‑deficiency anemia is associated with impaired immune function and can contribute to borderline low gamma‑globulin levels, highlighting the need to consider nutritional factors in the work‑up. 14

Prioritizing Diagnostic Work‑up in Autoimmune/Inflammatory Contexts

• In individuals who have iron‑deficiency anemia, a positive antinuclear antibody (ANA), and elevated C‑reactive protein (CRP), the first investigative priority should be assessment for underlying autoimmune or inflammatory disease and for gastrointestinal blood loss, rather than attributing the low‑normal gamma globulin to a primary immunodeficiency. 14